The Influence of Intranasal Oxytocin on Communication

Trial Profile

The Influence of Intranasal Oxytocin on Communication

Phase of Trial: Phase III

Latest Information Update: 02 Jan 2018

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Lactation failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Dec 2017 Planned number of patients changed from 600 to 200.
    • 27 Dec 2017 Status changed from not yet recruiting to recruiting.
    • 14 Nov 2016 Planned End Date changed from 1 Aug 2018 to 1 Aug 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top